Ingelsson E, Lundholm C, Johansson AL, Altman D. Hysterectomy and risk of cardiovascular disease: a population-based cohort study. Eur Heart J. 2011;32:745 750. 247. Jacoby VL, Grady D, Wactawski-Wende J, Manson JE, Allison MA, Kuppermann M, Sarto GE, Robbins J, Phillips L, Martin LW, O Sullivan MJ, Jackson R, Rodabough RJ, Stefanick ML. Oophorectomy vs ovar- ian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women s Health Initiative Observational Study. Arch Intern Med. 2011;171:760 768. 248. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent dis- ease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016 1037. 249. Paganini-Hill A. Hormone replacement therapy and stroke: risk, protec- tion or no effect? Maturitas. 2001;38:243 261. 250. Simon JA, Hsia J, Cauley JA, Richards C, Harris F, Fong J, Barrett- Connor E, Hulley SB. Postmenopausal hormone therapy and risk of stroke: the Heart and Estrogen-progestin Replacement Study (HERS). Circulation. 2001;103:638 642. 251. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med. 2001;345:1243 1249. 252. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N; HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [published correction appears in JAMA. 2002;288:1064]. JAMA. 2002;288:49 57. 253. 